Shots: The Ervebo has received approval in DRC, Burundi, Ghana, and Zambia, following the implementation of the WHO’s Roadmap for introduction & roll‐out of Merck’s rVSV-ZEBOV Ebola virus vaccine in […]readmore
Tags : Ervebo
Shots: The approval is based on the study conducted in Guinea during the 2014-2016 outbreak in individuals 18 years of age and older evaluated 3,537 contacts with laboratory-confirmed EVD who […]readmore
![Merck’s Ervebo [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Receives EC’s Conditional Approval to Prevent Ebola Virus Disease](https://pharmashots.in/wp-content/uploads/2019/11/Merck-18-850x560.jpg)
Shots: The EC has granted conditional marketing authorization to Ervebo for active immunization of individuals aged ≥ 18yrs. to protect against Ebola virus disease (EVD) caused by Zaire Ebola virus […]readmore